SanBio Co Stock

SanBio Co Forward P/E

The Forward P/E Ratio of SanBio Co (4592.T) as of Aug 7, 2026 is -55.43. In the previous year, Forward P/E Ratio was -60.44 — a change of -8.27% (higher).

Forward P/E

-55.43

YoY

-8.27%

Last updated:

Forward P/E Ratio of SanBio Co is 2026 -55.43 . Forward P/E Ratio of SanBio Co was 2025 -60.44 . It decreases by -8.27% higher compared to the previous year.
Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SanBio Co stock

Forward P/E Ratio of SanBio Co is -55.43 in 2026.

Forward P/E Ratio of SanBio Co changed from -60.44 to -55.43, representing a -8.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio SanBio Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's SanBio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — SanBio Co

All Key Metrics — SanBio Co